Acino in Africa
Our roots in Africa date back to 1992. In 2017, Acino acquired Litha Healthcare, significantly strengthening its presence in Southern Africa and establishing a strong foothold in Central East Africa and Mauritius. Since then, Acino has continued to expand its portfolio and broaden its offering in key therapeutic areas and markets.
In 2020, we accelerated our growth with the acquisition of Takeda’s primary care portfolio. This was followed by the acquisition of six prescription medicines from Aspen in 2022, which further demonstrated our commitment to South Africa and the region. In 2023, we secured an exclusive agreement to market and sell selected Janssen products. The following year, Ipsen transferred local responsibility for SOMATULINE® to Acino, thereby reinforcing our specialty care portfolio. We also successfully launched PARAGENGEN® IV and ORTACTA® and signed a licensing and supply agreement with Allecra Therapeutics for its novel antibiotic EXBLIFEP®.
Ranked 0th
Among private pharma companies in South Africa
0+
Products across Rx, OTC and medical kits
B-BBEE Level 0
Six consecutive years
Strategic Partnerships
In Africa, we collaborate with pharmaceutical companies of all sizes, from multinationals to small and medium-sized innovators to make high-quality medicines accessible to patients. We work with hospitals, pharmacies and healthcare professionals in 20 countries across the continent.
By leveraging our market presence and knowledge, our regulatory and go-to-market expertise*, and our world-class distribution, we help our partners navigate local complexities and bring innovative and proven medicines to those who need them most.
Partner with us to transform healthcare in emerging markets.
* Best Launched Product 2022 with CONTRAVE® – R13,7Mn sales.
Source: IQVIA Total Private Market MAT12/2022
Commitment to Africa
At Acino, we strive to expand access to healthcare, advance medical education, and drive innovation to enhance patient outcomes. In 2020, we have launched Acino EduDoc, a medical education empowering South African doctors with valuable knowledge and resources.
Our dedication to diversity and equal opportunity is reflected in our B-BBEE Level 1 status, which we have maintained for five consecutive years. As we grow, we take responsibility for promoting local employment, skills development, and initiatives such as YES4Youth to combat youth unemployment.
In addition, Acino Forensic assembles DNA evidence collection and crime scene kits, contributing to forensic advancements in the region.
Recognised as a Top Employer in South Africa for four consecutive years, Acino is a world-class workplace that fosters excellence and collaboration.
Join us in shaping the future of healthcare.
Contact Us
Fill out this form to get in touch with us.